{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:15:33Z","timestamp":1789676133284,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/ftd.0000000000000278","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T07:42:14Z","timestamp":1453880534000},"page":"365-370","source":"Crossref","is-referenced-by-count":15,"title":["Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy"],"prefix":"10.1097","volume":"38","author":[{"given":"Rui-Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Nan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5414\/CPP45047","article-title":"Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers","volume":"45","author":"Lins","year":"2007","journal-title":"Int J Clin Pharm Th"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer antiepileptic drugs","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007691-200302000-00009","article-title":"Correlation of levetiracetam concentrations between serum and saliva","volume":"25","author":"Grim","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7748\/nr2012.04.19.3.32.c9057","article-title":"Assessing children's and parents' opinions on salivary sampling for therapeutic drug monitoring","volume":"19","author":"Swallow","year":"2012","journal-title":"Nurse Res"},{"key":"R6-13-20210129","first-page":"172","article-title":"Correlation between serum and salivary phenytoin concentrations in Thai epileptic children","volume":"94","author":"Liamsuwan","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00007691-199009000-00016","article-title":"Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva","volume":"12","author":"Miles","year":"1990","journal-title":"Ther Drug Monit"},{"key":"R8-13-20210129","first-page":"517","article-title":"Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers","volume":"57","author":"Incecayir","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FTD.0b013e3180683d55","article-title":"Saliva and serum levetiracetam concentrations in patients with epilepsy","volume":"29","author":"Mecarelli","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00007691-200406000-00014","article-title":"Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD)","volume":"26","author":"Miles","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.aca.2009.12.030","article-title":"Liquid chromatographic analysis of oxcarbazepine and its metabolites in plasma and saliva after a novel microextraction by packed sorbent procedure","volume":"661","author":"Saracino","year":"2010","journal-title":"Anal Chim Acta"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/00003088-200342120-00002","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/0003088-200847120-00002","article-title":"Does oxcarbazepine warrant therapeutic drug monitoring? A critical review","volume":"12","author":"Bring","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00870993","article-title":"Use of saliva for monitoring oxcarbazepine therapy in epileptic patients","volume":"31","author":"Klitgaard","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/bdd.2510160708","article-title":"Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state","volume":"16","author":"Cardot","year":"1995","journal-title":"Biopharm Drug Distrib"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00609629","article-title":"Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers","volume":"22","author":"Theisohn","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1983.tb05340.x","article-title":"Pharmacokinetics of 10-OH carbamazepine the main metabolite of the antiepileptic oxcarbazepine from saliva and serum concentrations","volume":"68","author":"Kristensen","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"R18-13-20210129","first-page":"299","article-title":"Determination concentration of active metabolite of oxcarbazepine in human plasma and saliva by RP-HPLC","volume":"29","author":"Feng","year":"2013","journal-title":"Chin J Clin Pharmacol"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0404.1996.tb00016.x","article-title":"Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients","volume":"93","author":"May","year":"1996","journal-title":"Acta Neurol Scand"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:30:13Z","timestamp":1620952213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201606000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000278","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}